gout; Pericardial effusion; turned into pleural effusion cardiologist almost killed her; Had thoracic surgery; Cervical spondylosis; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient. A 67-year-old female patient received BNT162b2 (BNT162B2), on 06Apr2022 as dose 4 (booster), single (Lot number: FJ9943) at the age of 67 years for covid-19 immunisation. The patient's relevant medical history included: "Coronary artery disease with 7 stents" (unspecified if ongoing); "Coronary atherosclerosis" (unspecified if ongoing); "Angina" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "diabetes type 2" (unspecified if ongoing); "Acquired hypothyroidism" (unspecified if ongoing); "Osteopetrosis" (unspecified if ongoing), notes: from taking Synthroid Started Probably like 3 years ago; "Seronegative arthritis" (unspecified if ongoing); "Adhesive capsulitis" (unspecified if ongoing), notes: Adhesive capsulitis Known as frozen shoulder; "Skin allergies" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing); "autoimmune inflammation" (unspecified if ongoing); "non rheumatic mitral regurgitation" (unspecified if ongoing), notes: Still trying to get answer about that one; "thyroid cancer" (ongoing); "Diabetes" (ongoing); "chronic responsive pain syndrome from ankle injury" (ongoing); "heart" (ongoing); "Cholesterol" (ongoing); "stroke" (ongoing); "guess it is mood stabilizer" (ongoing); "Constipation" (ongoing); "nausea from swallowing all these pills" (ongoing), notes: nausea from swallowing all these pills; "Cervical spondylosis", start date: Jul2022 (unspecified if ongoing); "Blood pressure" (ongoing); "immunocompromised" (unspecified if ongoing); "multiple vitamin" (ongoing). Concomitant medications included: SYNTHROID [reported has been taking about 10 years  ] taken for thyroid cancer (ongoing); METFORMIN [reported probably about 10 years] taken for diabetes mellitus (ongoing); HUMALOG [reported been taking probably 9 years] taken for diabetes mellitus (ongoing); LEVEMIR  [reported has been taking for 10 years]taken for diabetes mellitus (ongoing); PREGABALIN [reported been taking a couple years] taken for complex regional pain syndrome (ongoing); ASPIRIN [ACETYLSALICYLIC ACID] [reported been forever, 20 years] taken for cardiac disorder (ongoing); CARVEDILOL [been taking, probably about a year] taken for cardiac disorder, blood pressure abnormal (ongoing); ENALAPRIL [reported been taking probably different dose for 20 years] taken for blood pressure measurement (ongoing); ATORVASTATIN [reported probably been taking for 5 or 7 years] taken for blood cholesterol abnormal (ongoing); VASCEPA [reported been taking probably 2 years] taken for blood cholesterol abnormal (ongoing); XANAX [has been on it about 23 years] taken for cerebrovascular accident (ongoing); FLUOXETINE taken for affective disorder, start date: 2017 (ongoing); COLACE [reported taking maybe like 3 years] taken for constipation (ongoing); VITAMIN D3 [reported to be on it a few years ago] (ongoing); CENTRUM SILVER WOMEN 50+ [reported as always taken vitamins] taken for vitamin supplementation (ongoing); TYLENOL (ongoing); ZOFRAN [ONDANSETRON] [reported at least 3 or 4 years] taken for nausea (ongoing); COLCHICINE taken for inflammation, start date: Aug2022 (ongoing); BRILINTA taken for anticoagulant therapy, start date: Aug2022 (ongoing). Past drug history included: Metformin, reaction(s): "has significant B12 deficiency", notes: he never tested her for B12. As result of B12, she is now anemic. Vaccination history included: BNT162b2 (Dose 3; Lot number: EW0185), administration date: 03Sep2021, when the patient was 66-year-old, for COVID-19 immunization; BNT162b2 (Dose 2; lot number: EP7533), administration date: 26Mar2021, when the patient was 66-year-old, for COVID-19 immunization; BNT162b2 (Dose 1; lot number: EN6206), administration date: 05Mar2021, when the patient was 66-year-old, for COVID-19 immunization. The following information was reported: SPINAL OSTEOARTHRITIS (non-serious) with onset Jul2022, outcome "unknown", described as "Cervical spondylosis"; THORACIC OPERATION (medically significant) with onset Aug2022, outcome "unknown", described as "Had thoracic surgery"; PERICARDIAL EFFUSION (medically significant, life threatening) with onset Sep2022, outcome "unknown"; PLEURAL EFFUSION (life threatening) with onset Sep2022, outcome "unknown", described as "turned into pleural effusion cardiologist almost killed her"; GOUT (non-serious), outcome "unknown". The patient underwent the following laboratory tests and procedures: Weight: 150, notes: Probably about 150 today. Therapeutic measures were taken as a result of thoracic operation, gout. Additional information: The patient reported that she had to receive a 3rd and subsequent dose administered since CDC said so. She received her 3rd dose in her house. The adverse events did not require any visit (facility). The patient inquired if an additional dose is required as they are recommending another booster for compromised patients